Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study.

Hicks C, King MS, Gulick RM, White AC Jr, Eron JJ Jr, Kessler HA, Benson C, King KR, Murphy RL, Brun SC.

AIDS. 2004 Mar 26;18(5):775-9.

PMID:
15075512
2.

[The "induction-maintenance" strategy].

Arribas López JR.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:8-11. Review. Spanish.

PMID:
19572438
3.

Stavudine once daily.

Cheer SM, Goa KL.

Drugs. 2002;62(18):2667-74; discussion 2675-6. Review.

PMID:
12466009
4.

Resolution of HIV-associated nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube.

Viani RM, Dankner WM, Muelenaer PA, Spector SA.

Pediatrics. 1999 Dec;104(6):1394-6. Review.

PMID:
10585995
5.

Lopinavir/Ritonavir: a review of its use in the management of HIV-1 infection.

Croxtall JD, Perry CM.

Drugs. 2010 Oct 1;70(14):1885-915. doi: 10.2165/11204950-000000000-00000. Review.

PMID:
20836579
6.

[Treatment of HIV infections with antiretroviral drugs and recombinant interleukin-2].

Dragsted UB, Afzelius P, Nielsen SD, Lundgren JD.

Ugeskr Laeger. 2000 Oct 16;162(42):5614-8. Review. Danish.

PMID:
11059298
7.

Initial antiretroviral therapy in chronically-infected HIV-positive adults.

Temesgen Z, Cainelli F, Warnke D, Koirala J; Collaborative Research Network (CORNET) Investigators..

Expert Opin Pharmacother. 2004 Mar;5(3):595-612. Review.

PMID:
15013928
8.

Impact of hepatitis C co-infection on response to antiretroviral treatment.

Pulido F, Hill A, van Delft Y, Moecklinghoff C.

AIDS Rev. 2012 Apr-Jun;14(2):124-31. Review.

PMID:
22627608
9.

The reassurance of experience.

Martínez E.

Int J STD AIDS. 2003 Oct;14 Suppl 1:20-8. Review.

PMID:
14617400
10.

[New strategies in the optimisation of lopinavir/ritonavir doses in human immunodeficiency virus-infected patients].

López Aspiroz E, Cabrera Figueroa SE, Domínguez-Gil Hurlé A, García Sánchez MJ.

Enferm Infecc Microbiol Clin. 2013 Jan;31(1):36-43. doi: 10.1016/j.eimc.2011.11.018. Review. Spanish.

PMID:
22280562
11.

Biologic effects and safety of stavudine: overview of phase I and II clinical trials.

Skowron G.

J Infect Dis. 1995 Mar;171 Suppl 2:S113-7. Review.

PMID:
7861015
12.

Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients.

Baril JG, Angel JB, Gill MJ, Gathe J, Cahn P, van Wyk J, Walmsley S.

PLoS One. 2016 Feb 5;11(2):e0148231. doi: 10.1371/journal.pone.0148231. Review.

13.

Antiretroviral drugs in pediatrics.

Rongkavilit C, Asmar BI.

Indian J Pediatr. 2001 Jul;68(7):641-7. Review.

PMID:
11519288
Items per page

Supplemental Content

Support Center